Dan Kisner
Chairman at HISTOGEN INC.
Net worth: 24 068 $ as of 30/03/2024
Profile
Daniel L.
Kisner is currently the Chairman at Idun Pharmaceuticals, Inc. He is also the Non-Executive Chairman at Histogen, Inc. since 2014, an Independent Director at Dynavax Technologies Corp.
since 2010, a Director at Lpath Therapeutics, Inc., and an Independent Director at Oncternal Therapeutics, Inc. since 2019.
Previously, Dr. Kisner served as the Chairman at Caliper Life Sciences, Inc. from 2002 to 2008.
He was also the Chairman at Sequoia Pharmaceuticals, Inc., Avera Pharmaceuticals, Inc., Arbutus Biopharma Corp., and Caliper Technologies Corp.
from 1999 to 2008.
Additionally, he held positions as a Director at Pfizer Inc., Sequenom, Inc., Kémia, Inc., Tolerx, Inc. from 2001 to 2011, EMulate Therapeutics, Inc., KAI Pharmaceuticals, Inc., Conatus Pharmaceuticals, Inc., Zynerba Pharmaceuticals, Inc. from 2015 to 2023, Adaptive Therapeutics, Inc., Lpath, Inc. from 2012 to 2016, MPEX Pharmaceuticals, Inc., Symphony Allegro, Inc., and Oncternal Oncology, Inc.Dr. Kisner started his career as the Vice President-Pharmaceutical Development at Abbott Laboratories from 1988 to 1991.
He then became the President & Chief Operating Officer at Ionis Pharmaceuticals, Inc. from 1991 to 1999.
He was also a Partner at Aberdare Ventures from 2003 to 2011 and served as the Vice President-Clinical Research & Development at Smithkline Beckman Corp from 1985 to 1988.
Dr. Kisner obtained his undergraduate degree from Rutgers State University of New Jersey and his doctorate degree from Georgetown University in 1972.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
14/03/2024 | 1,500 ( 0.00% ) | 18 615 $ | 30/03/2024 | |
27/06/2023 | 604 ( 0.02% ) | 5 436 $ | 30/03/2024 | |
HISTOGEN INC.
0.00% | 19/06/2023 | 47 ( 0.00% ) | 17 $ | 30/03/2024 |
Dan Kisner active positions
Companies | Position | Start |
---|---|---|
DYNAVAX TECHNOLOGIES CORPORATION | Director/Board Member | 21/07/2010 |
ONCTERNAL THERAPEUTICS, INC. | Director/Board Member | 06/06/2019 |
HISTOGEN INC. | Chairman | 09/03/2023 |
Lpath Therapeutics, Inc.
Lpath Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Boston Scientific Corp., Lpath Therapeutics, Inc. develops pharmaceutical products focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases. The private company is based in San Diego, CA. Lpath Therapeutics was acquired by Neighborhood Connections, Inc. on November 30, 2005 for $23.13 million. | Director/Board Member | - |
Idun Pharmaceuticals, Inc.
Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Chairman | - |
Former positions of Dan Kisner
Companies | Position | End |
---|---|---|
ZYNERBA PHARMACEUTICALS, INC. | Director/Board Member | 09/10/2023 |
Lpath, Inc.
Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Director/Board Member | 30/11/2016 |
Avera Pharmaceuticals, Inc.
Avera Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Avera Pharmaceuticals, Inc. develops drugs and therapies. The company's pharmaceutical compounds are used to identify opportunities for therapeutic advances in the treatment of neurological and psychiatric disorders. Avera Pharmaceuticals was founded in 2002 and is headquartered in San Diego, CA. | Chairman | 07/07/2013 |
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | Director/Board Member | 18/12/2011 |
░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Dan Kisner
Rutgers State University of New Jersey | Undergraduate Degree |
Georgetown University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 8 |
---|---|
ABBOTT LABORATORIES | Health Technology |
PFIZER, INC. | Health Technology |
IONIS PHARMACEUTICALS, INC. | Health Technology |
DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
ARBUTUS BIOPHARMA CORPORATION | Health Technology |
ZYNERBA PHARMACEUTICALS, INC. | Health Technology |
ONCTERNAL THERAPEUTICS, INC. | Health Technology |
HISTOGEN INC. | Health Technology |
Private companies | 19 |
---|---|
Caliper Life Sciences, Inc.
Caliper Life Sciences, Inc. SemiconductorsElectronic Technology Caliper Life Sciences, Inc. develops, manufactures, and sells labchip systems. It offers microfluids, lab automation, liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. The company was founded by Michael R. Knapp on July 26, 1995 and is headquartered in Hopkinton, MA. | Electronic Technology |
Sequenom, Inc.
Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC. | Health Technology |
Sequoia Pharmaceuticals, Inc.
Sequoia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sequoia Pharmaceuticals discovers and develops unique treatments for viral diseases including HIV/AIDS and HCV-induced hepatitis with a focus on the growing global problem of drug-resistant disease. Most new anti-viral drugs were designed to block the most prevalent form of a pathogen, but these drugs become less potent due to the emergence of drug-resistant mutations. Sequoia's is to discover and develop new antiviral which are active against the most prevalent form of the virus but also anticipates the emergence of drug resistance forms thereby maintaining potency over time. Sequoia's differentiating approach is to identify a constellation of atomic interaction points which are necessary and sufficient for enzymatic function. Sequoia's protease inhibitors have been designed to interact preferentially with only these atoms, thus allowing non-critical mutations to occur without resulting in a decrease in drug potency. The foundation of Sequoia's novel Resistant-Repellent™ technology is a drug discovery tool that enhances the efficiency with which drugs are designed. It is based on an understanding of the chemical and physical nature of the molecular targets, the enzymes and receptors to which drugs bind, combined with an understanding of the molecular mechanisms that cause drug resistance. Sequoia is also discovering and developing a unique series of pharmacokinetic enhancers (PKEs) to work in combination with its own, and its partners', antiviral therapies. These sets of molecules improve the PK of existing therapeutics and reduce interpatient variability. This represents a unique approach to an important need in HIV treatment today. Sequoia is also looking to extend this novel PKE approach to other areas. Its PKEs are designed to inhibit a particular CYP isozyme and therefore change the metabolism of a co-administered therapeutic agent. The combination of PK Enhancer and the therapeutic agent enables reduced dosage and less frequent administration of the therapeutic agent. | Health Technology |
Kémia, Inc.
Kémia, Inc. Pharmaceuticals: MajorHealth Technology Kémia, Inc. discovered and developed novel small molecule therapeutics for inflammation, cancer, HIV, diabetes and bone diseases. The firm specialized in the fields of medicinal and analytical chemistry, biology, pharmacology, pharmacokinetics, pharmacodynamics, and clinical development. The company was founded in 2002 and was headquartered in San Diego, CA. | Health Technology |
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | Health Technology |
Avera Pharmaceuticals, Inc.
Avera Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Avera Pharmaceuticals, Inc. develops drugs and therapies. The company's pharmaceutical compounds are used to identify opportunities for therapeutic advances in the treatment of neurological and psychiatric disorders. Avera Pharmaceuticals was founded in 2002 and is headquartered in San Diego, CA. | Health Services |
Idun Pharmaceuticals, Inc.
Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Health Technology |
EMulate Therapeutics, Inc.
EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA. | Health Technology |
KAI Pharmaceuticals, Inc.
KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Conatus Pharmaceuticals, Inc.
Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA. | Health Technology |
Aberdare Ventures
Aberdare Ventures Investment ManagersFinance Aberdare Management Co. LLC (Aberdare Ventures) is a venture capital firm founded in 1999 by Paul H. Klingenstein. The firm is headquartered in San Francisco, California. | Finance |
Smithkline Beckman Corp
Smithkline Beckman Corp Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Smithkline Beckman Corp is a private company that manufactures pharmaceutical products. The company is based in Philadelphia, PA. Smithkline Beckman was acquired by Smithkline Beecham Plc on July 27, 1989 for $16,082.37 million. | Health Technology |
Adaptive Therapeutics, Inc.
Adaptive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adaptive Therapeutics, Inc. develops pharmaceutical products. It develops drugs for applications in anti-bacterial, fungal, viral, and cancer therapeutics. The company was founded in 2002 and is headquartered in San Diego, CA | Health Technology |
Lpath Therapeutics, Inc.
Lpath Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Boston Scientific Corp., Lpath Therapeutics, Inc. develops pharmaceutical products focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases. The private company is based in San Diego, CA. Lpath Therapeutics was acquired by Neighborhood Connections, Inc. on November 30, 2005 for $23.13 million. | Health Technology |
Lpath, Inc.
Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Health Technology |
MPEX Pharmaceuticals, Inc.
MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services MPEX Pharmaceuticals, Inc. develops and manufactures therapies for antibiotic resistance with focus on gram-negative organisms. It offers Aeroquin (MP- 376), an aerosol formulation of levofloxacin for the treatment of pulmonary infections in patients with cystic fibrosis, as well as antibiotic programs to address antibiotic resistance in gram negative organisms. The company was founded in 2001 and is headquartered in San Diego, CA. | Commercial Services |
Caliper Technologies Corp.
Caliper Technologies Corp. Medical SpecialtiesHealth Technology Caliper Technologies Corp. is a private company that provides microfluidic technology and laboratory automation solutions to the life science, biotechnology, and pharmaceutical industries worldwide. The company is based in Mountain View, CA. The company was founded by J. Michael Ramsey. | Health Technology |
Symphony Allegro, Inc.
Symphony Allegro, Inc. Pharmaceuticals: MajorHealth Technology Symphony Allegro, Inc. manufactures biopharmaceutical drugs. It develops clinical trials for the treatment of schizophrenia, bipolar, migraine, and panic attack disorders. The company was founded in 2006 and is headquartered in Rockville, MD. | Health Technology |
Oncternal Oncology, Inc.
Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Oncternal Oncology, Inc. is a clinical-stage oncology company, which engages in the development of novel therapies for both rare and common cancers. The company was founded by Lauren Otsuki and Cam L. Garner and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Dan Kisner